This risk could potentially be reduced through the use of biological therapies.267–270 In RA patients receiving TNF-α antagonists, an inverse correlation was found between initial PCSK9 levels and disease activity extent. This evidence concerns the gene PCSK9 and rheumatoid arthritis.